Skip to Main Content

For further information, see CMDT Part 33-39: Chlamydia trachomatis Infections

Key Features

  • Chlamydia trachomatis immunotypes D–K are isolated in about 50% of cases of nongonococcal urethritis and cervicitis by appropriate techniques

  • Coinfection with gonococci is common

  • Postgonococcal (ie, chlamydial) urethritis may persist after successful treatment of the gonococcal component

  • Long-term sequelae may include ectopic pregnancy and infertility

Clinical Findings

  • Urethritis and occasionally epididymitis, prostatitis, or proctitis

  • Women may be asymptomatic or may have symptoms and signs of cervicitis, salpingitis, or pelvic inflammatory disease

Diagnosis

  • The urethral or cervical discharge due to C trachomatis tends to be less painful, less purulent, and watery compared with gonococcal infection

  • A patient with clinical signs and symptoms of urethritis or cervicitis is assumed to have chlamydial infection until proven otherwise

  • Sensitive and specific nucleic acid amplification tests permit diagnosis of both chlamydia infection and gonorrhea on a vaginal swab or urine sample

Treatment

  • Doxycycline, 100 mg orally twice daily for 7 days, is the preferred regimen but is contraindicated in pregnancy

  • Alternative regimen

    • Levofloxacin 500 mg orally once daily for 7 days

    • Azithromycin 1 g orally as a single dose (preferred in pregnancy)

  • Presumptively administered therapy still indicated in some cases

    • Individuals with gonococcal infection in whom no chlamydial testing was performed or a test other than a nucleic acid amplification test was used to exclude the diagnosis

    • Individuals for whom a test result is pending but are considered unlikely to follow up

    • Sexual contacts of documented cases

  • Studies for HIV and syphilis should also be performed

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.